36 research outputs found

    Additional file 1: Table S1. of Bat rabies surveillance in France: first report of unusual mortality among serotine bats

    No full text
    Results of passive bat rabies surveillance undertaken in Moselle and Meurthe & Moselle. Results are detailed by department, date, city of isolation and species of bats. (DOCX 23 kb

    Rabies occurrence rate detected in serotine bats in France from 1989–2013 in the frame of the bat rabies surveillance network and according different environmental factors: season (a), year (b), regional cluster (c) and sex (d).

    No full text
    <p>Rabies occurrence rate detected in serotine bats in France from 1989–2013 in the frame of the bat rabies surveillance network and according different environmental factors: season (a), year (b), regional cluster (c) and sex (d).</p

    Bat rabies in France.

    No full text
    <p>Negative case: black dot, positive case: red triangle (A). Distribution of all the bat samples analysed for rabies diagnosis; A1)1989–2000; A2) 2001–2013 (B). Location of serotine (<i>Eptesicus serotinus</i>) samples analysed for rabies diagnosis; B1)1989–2000; B2)2001–2013.</p

    Regional clusters with geographical location of the 47 EBLV-1 a and b samples according to the results of the phylogenetic N gene analysis.

    No full text
    <p>Samples were located geographically according to the defined lineage: [B1 (north-west), B2 (centre), B3 (north -east)] and A (south-west)]. The numbers correspond to the identification numbers of isolates</p

    Neigbour-Joining and Bayesian Phylogenetics.

    No full text
    <p>A. NJ phylogenetic tree comparing partial N gene sequence from 32 French EBLV-1 isolates from 1989–2012, 11 referenced European EBLV-1 strains (Poland, Holland, Luxembourg, Spain, Denmark, Germany, Russia), 1 EBLV-1 isolate from Luxembourg, 5 EBLV-2 strains (Finland, Germany, United Kingdom, Switzerland, Holland) and two BBLV isolates (France, Germany). Relationships are presented as a rooted phylogram with WCBV (EF614258). Bootstraps above 70% are significant.</p

    Overview of the cost of OV in Estonia, Latvia and Lithuania from 2006 to 2011.

    No full text
    a<p>: between (y) and (y−1).</p>b<p>: 1 OV campaign.</p>c<p>: 75% of EC funding.</p>d<p>: It is assumed that the effect of OV is observable at year y+1. This ratio corresponds to the EC funding from 2006 to 2009/newly uninfected area from 2007 to 2010.</p><p>(M): Mean value.</p><p>This table shows the number of baits used, the funding allocated for rabies prevention by the European Commission (EC) “approving annual and multi-annual programmes and the financial contribution”, the area vaccinated, the uninfected and newly uninfected areas and the type of vaccine used. Different ratios were calculated : Number of baits distributed from 2006–2011 per country per vaccinated area in km<sup>2</sup>. EC funding over the 2006–2010 period/newly uninfected areas in the country in km<sup>2</sup>.</p
    corecore